Indian Drugmaker Dr Reddy’s Gets Brazil Regulator Nod to Sell Generic Ozempic

Indian drugmaker Dr Reddy’s gets Brazil regulator nod to sell generic Ozempic - Regional Media News

Nov 5 (Reuters) - Indian drugmaker Dr Reddy's Laboratories said on Thursday it had received regulatory approval in Brazil to market and sell a generic version of Novo Nordisk's blockbuster diabetes drug Ozempic. • Brazil has 16.6 million adults aged between 20 and 79 living [...]

Indian drugmaker Dr Reddy’s gets Brazil regulator nod to sell generic Ozempic

Nov 5 (Reuters) - Indian drugmaker Dr Reddy's Laboratories said on Thursday it had received regulatory approval in Brazil to ​market and sell a generic version ‌of Novo Nordisk's blockbuster diabetes drug Ozempic. • Brazil has 16.6 million adults aged ...

Dr. Reddy’s gets marketing authorisation for generic semaglutide injection in Brazil

Approval expands access for type 2 diabetes treatment; company plans launch with Aché in $244.6 million market

Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in Brazil

Dr Reddys Laboratories obtained marketing authorisation from Brazils ANVISA for a generic semaglutide injection. The product will be available as a pre-filled, multi-dose pen in two dosages for weekly administration. This drug targets treatment for type 2 diabetes alongside diet and exercise, particularly in patient groups needing alternative therapies. Brazil's diabetes prevalence creates significant market demand, estimated at approximately $2…

Dr. Reddy’s receives marketing authorisation for generic semaglutide injection in Brazil

The approval expands Dr. Reddy’s semaglutide presence to Brazil, one of the key markets in Latin America

Dr Reddy's Gets Brazil Nod for Generic Semaglutide Injection

On 5 November, Dr Reddy’s Laboratories Ltd won ANVISA approval in Brazil for its generic semaglutide injection for adults with type 2 diabetes. The Hyderabad-based drugmaker disclosed the nod in a filing with the National Stock Exchange. Brazil’s health regulator granted the marketing authorisation. The injection is for adults whose...